Tiffani K. Hamilton

1.8k total citations
25 papers, 1.2k citations indexed

About

Tiffani K. Hamilton is a scholar working on Dermatology, Immunology and Molecular Biology. According to data from OpenAlex, Tiffani K. Hamilton has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Dermatology, 11 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Tiffani K. Hamilton's work include Psoriasis: Treatment and Pathogenesis (10 papers), Facial Rejuvenation and Surgery Techniques (6 papers) and Dermatology and Skin Diseases (6 papers). Tiffani K. Hamilton is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (10 papers), Facial Rejuvenation and Surgery Techniques (6 papers) and Dermatology and Skin Diseases (6 papers). Tiffani K. Hamilton collaborates with scholars based in United States, Canada and Sweden. Tiffani K. Hamilton's co-authors include Wolfgang Dummer, Patricia A. Walicke, Alan Menter, Stephen K. Tyring, Darryl Toth, David M. Pariser, Marvin R. Garovoy, Scott D. Glazer, Xiaolin Wang and Mark Lebwohl and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of the American Academy of Dermatology.

In The Last Decade

Tiffani K. Hamilton

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tiffani K. Hamilton United States 14 829 505 221 165 147 25 1.2k
Yoshinori Umezawa Japan 23 857 1.0× 551 1.1× 159 0.7× 252 1.5× 98 0.7× 71 1.3k
Darryl Toth Canada 14 1.2k 1.4× 954 1.9× 283 1.3× 321 1.9× 112 0.8× 33 1.7k
J.M.P.A. van den Reek Netherlands 20 785 0.9× 470 0.9× 98 0.4× 217 1.3× 50 0.3× 41 1.1k
Kara N. Shah United States 14 434 0.5× 291 0.6× 118 0.5× 174 1.1× 85 0.6× 28 860
T.N. Dam Denmark 14 753 0.9× 462 0.9× 119 0.5× 145 0.9× 83 0.6× 21 1.0k
C. Bulaï Livideanu France 17 387 0.5× 245 0.5× 159 0.7× 299 1.8× 56 0.4× 81 824
Sophie Hugot Switzerland 9 1.0k 1.2× 577 1.1× 221 1.0× 378 2.3× 70 0.5× 10 1.3k
B Berner Germany 12 742 0.9× 204 0.4× 101 0.5× 285 1.7× 140 1.0× 15 1.0k
Nikolai Loft Denmark 18 559 0.7× 516 1.0× 76 0.3× 228 1.4× 75 0.5× 51 1.0k
Isabelle Hampele United States 6 1.3k 1.6× 751 1.5× 261 1.2× 344 2.1× 84 0.6× 8 1.6k

Countries citing papers authored by Tiffani K. Hamilton

Since Specialization
Citations

This map shows the geographic impact of Tiffani K. Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffani K. Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffani K. Hamilton more than expected).

Fields of papers citing papers by Tiffani K. Hamilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffani K. Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffani K. Hamilton. The network helps show where Tiffani K. Hamilton may publish in the future.

Co-authorship network of co-authors of Tiffani K. Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffani K. Hamilton. A scholar is included among the top collaborators of Tiffani K. Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffani K. Hamilton. Tiffani K. Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holcomb, J. David, et al.. (2020). A Prospective Study Evaluating the Use of Helium Plasma for Dermal Resurfacing. Lasers in Surgery and Medicine. 52(10). 940–951. 16 indexed citations
2.
Sofen, Howard, Kenneth G. Gross, Leonard H. Goldberg, et al.. (2015). A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma. Journal of the American Academy of Dermatology. 73(1). 99–105.e1. 56 indexed citations
3.
Hamilton, Tiffani K., et al.. (2015). Hypersensitivity pneumonitis in a high school teacher. Occupational Medicine. 65(7). 598–600. 2 indexed citations
4.
Bassichis, Benjamin A., Gary Blick, Marcus A. Conant, et al.. (2012). Injectable Poly-l-Lactic Acid for Human Immunodeficiency Virus–Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open-Label Study (FACES). Dermatologic Surgery. 38(7). 1193–1205. 15 indexed citations
6.
Leonardi, C., et al.. (2008). Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis. British Journal of Dermatology. 158(5). 1107–1116. 62 indexed citations
7.
Hamilton, Tiffani K., Alan Menter, Ivor Caro, et al.. (2008). Safety of Efalizumab Therapy in Patients with Moderate to Severe Psoriasis. Drug Safety. 31(8). 715–726. 7 indexed citations
8.
Gordon, Kenneth B., Robin R. Blum, Kim Papp, et al.. (2007). Efficacy and Safety of Adalimumab Treatment in Patients with Moderate to Severe Psoriasis: A Double-Blind, Randomized Clinical Trial. 13a(1). 4–11. 20 indexed citations
9.
Menter, Alan, Tiffani K. Hamilton, Darryl Toth, et al.. (2007). Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open‐label, multicenter, Phase IIIb study. International Journal of Dermatology. 46(6). 637–648. 27 indexed citations
10.
Hamilton, Tiffani K.. (2007). Assessing nonsurgical options for facial restoration. Dermatologic Therapy. 20(s1). S5–S9. 4 indexed citations
11.
Hamilton, Tiffani K.. (2005). Clinical considerations of efalizumab therapy in patients with psoriasis. Seminars in Cutaneous Medicine and Surgery. 24(1). 19–27. 26 indexed citations
12.
Lebwohl, Mark, Stephen K. Tyring, Tiffani K. Hamilton, et al.. (2003). A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis. New England Journal of Medicine. 349(21). 2004–2013. 424 indexed citations
13.
Gordon, Kenneth B., Kim Papp, Tiffani K. Hamilton, et al.. (2003). Efalizumab for Patients With Moderate to Severe Plaque Psoriasis. JAMA. 290(23). 3073–3073. 314 indexed citations
14.
Hamilton, Tiffani K., et al.. (2000). Congenital and childhood dermatofibrosarcoma protuberans: A case report and review of the literature. Journal of the American Academy of Dermatology. 42(5). 907–913. 53 indexed citations
15.
Hamilton, Tiffani K., et al.. (1999). Persistent Pruritic Plaque of the Ear. Archives of Dermatology. 135(4). 463–b. 6 indexed citations
16.
Hamilton, Tiffani K. & Kathryn A. Zug. (1998). Systemic Contact Dermatitis to Raw Cashew Nuts in a Pesto Sauce. Dermatitis. 9(1). 51–54. 5 indexed citations
17.
Hamilton, Tiffani K. & Kathryn A. Zug. (1998). Systemic Contact Dermatitis to Raw Cashew Nuts in a Pesto Sauce. American Journal of Contact Dermatitis. 9(1). 51–54. 6 indexed citations
18.
Hamilton, Tiffani K.. (1998). Systemic contact dermatitis to raw cashew nuts in a pesto sauce. American Journal of Contact Dermatitis. 9(1). 51–54. 15 indexed citations
19.
Hamilton, Tiffani K.. (1996). Triethanolamine allergy inadvertently discovered from a fluorescent marking pen. American Journal of Contact Dermatitis. 7(3). 164–165. 8 indexed citations
20.
Petersen, Marta J., et al.. (1995). REGULATION and INHIBITION OF COLLAGENASE EXPRESSION BY LONG‐WAVELENGTH ULTRAVIOLET RADIATION IN CULTURED HUMAN SKIN FIBROBLASTS*. Photochemistry and Photobiology. 62(3). 444–448. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026